The rabies treatment market size has the potential to grow by USD 1.06 billion during 2020-2024, and the market's growth momentum will accelerate at a CAGR of 4.67%.
This report provides a detailed analysis of the market by product (vaccines and RIG), application (pre-exposure vaccination and post-exposure prophylaxis), route of administration (intradermal route of administration, intramuscular route of administration, and oral route of administration), geography (Asia, Europe, North America, and ROW), and key vendors.
Browse TOC and LoE with selected illustrations and example pages of Rabies Treatment Market
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
Bavarian Nordic AS
Bharat Biotech Ltd.
Boehringer Ingelheim International GmbH
Elanco Animal Health Inc.
Merck & Co. Inc.
Serum Institute of India Pvt. Ltd.
The rabies treatment market is concentrated and the vendors are deploying organic growth strategies to compete in the market. Click here to uncover other successful business strategies deployed by the vendors.
The market players also significantly leverage external market drivers such as the need for contamination-free vaccines with novel culture media to achieve growth opportunities. However, factors such as wide host range and geographical presence will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Download a free sample of the rabies treatment market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies,
This rabies treatment market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities. Grab your Free Sample nowto unlock further information on other key market drivers
Rabies Treatment Market: Segmentation by Geography
45% of the market's growth will originate from Asia during the forecast period. China and Japan are the key markets for rabies treatment in Asia. Market growth in this region will be faster than the growth of the market in other regions.
The increasing awareness about the vaccinations of dogs is one of the prime factors that will facilitate the rabies treatment market growth in Asia over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.
The dominance of the vaccines segment is due to the established adoption of CCVs among end-users owing to its benefits such as high immunogenicity and fewer side-effects. Hence the vaccines market segment will exhibit faster growth rate than RIG during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the rabies treatment market size. Fetch actionable market insights on post COVID-19 impact on each segment.
Rabies Treatment Market: Key Highlights of the Report for 2020-2024
CAGR of the market during the forecast period 2020-2024
Detailed information on factors that will drive rabies treatment market growth during the next five years
Precise estimation of the rabies treatment market size and its contribution to the parent market
Accurate predictions on upcoming trends and changes in consumer behavior
The growth of the rabies treatment industry across Asia, Europe, North America, and ROW
A thorough analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of rabies treatment market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Rabies Treatment Market Scope
Growth momentum & CAGR
Accelerate at a CAGR of 5%
Market growth 2020-2024
$ 1.06 billion
YoY growth (%)
Asia, Europe, North America, and ROW
Performing market contribution
Asia at 45%
Key consumer countries
China, US, UK, Japan, and France
Leading companies, competitive strategies, consumer engagement scope
Bavarian Nordic AS, Bharat Biotech Ltd., Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Grifols SA, Kedrion Spa, Merck & Co. Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Zoetis Inc.
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Bavarian Nordic AS, Bharat Biotech Ltd., Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Grifols SA, Kedrion Spa, Merck & Co. Inc., Sanofi, Serum Institute of India Pvt. Ltd., Zoetis Inc. are a few of the key vendors in the rabies treatment market.